An interesting dialogue on evidence and recommendations on decriminalisation

Together with our project partners C-EHRN, EHRA, EuroNPUD, the Drug Policy Network South East Europe hosted a Webinar on Decriminalisation of drug use and possession for personal use on 4 December 2025. The aim of the webinar was to present and discuss a policy brief developped in scope of the BOOST project.

The webinar was held in English and Russian. 32 participants from various European countries participated – experts, activists, and policymakers. They demonstrated that the true threat to European safety is not the substances themselves, but a punitive system that costs taxpayers billions, fuels organized crime, and destroys lives.

Marios Atzemis, DPNSEE Board member, presented the policy brief ondecriminalization, highlighting its importance for health, dignity, and human rights, and shared personal experiences on the impact of criminalization.

The fiscal and moral bankruptcy of criminalization

The conversation at the webinar began not with ideology, but with hard accounting. For years, governments in Central and Eastern Europe and Central Asia (CEECA) have claimed they “cannot afford” comprehensive harm reduction services. New data presented by EHRA Executive Director Ganna Dovbakh exposed this as a fiscal lie.

Presenting an updated 2025 comparative analysis of criminalization costs, Dovbakh revealed a staggering gap: in many CEECA countries, imprisoning one person for a drug offense costs the state up to 19 times more than providing that same person with a full package of health and social services (including Opioid Agonist Treatment and harm reduction) in the community.

 

A full regional comparison and country profiles are available following this link>>>.

But the cost is not merely financial; it is human. To expose this reality, Maria Plotko (EHRA) unveiled “Drug Policy and Economic, Social and Cultural Rights in the CEECA Region” a vital new resource developed by EHRA in partnership with the Helsinki Foundation for Human Rights (HFHR).

Designed to inform the upcoming UN CESCR General Comment, this report acts as a roadmap for civil society, documenting how punitive policies violate rights far beyond the traditional scope of health. The findings-based on consultations across 19 countries reveal a system of “invisible punishment”:

  • Right to Work: Administrative fines often lead to total wage garnishment, forcing people out of the formal economy, while rigid OAT schedules and workplace testing prevent stable employment.
  • Right to Family: In countries like Uzbekistan and Tajikistan, mandatory testing is required before marriage, and people with a history of drug use are often barred from adopting children.
  • Social Security & Housing: “Drug registries” create a catch-22 where individuals are denied state support or housing eligibility based on their status.

The Netherlands: Fixing the “Back Door” Paradox

John-Peter Kools of the Trimbos Institute provided a critical reality check on the famous “Dutch Model.” He clarified that the Netherlands does not have full de jure decriminalisation, but rather a 50-year-old policy of “tolerance.”

While this separation of markets (coffee shops) successfully decriminalised consumption, it left a dangerous legal gap: the supply chain remained illegal (the “back door” problem). This created a paradox where sale is tolerated, but production is criminal, empowering organized crime.

To solve this, Kools highlighted the Netherlands’ bold new step: The Controlled Cannabis Supply Chain Experiment. Currently rolling out in 10 cities, this pilot legalises the entire chain from production to sale. “Decriminalisation of use is not enough,” Kools noted. “Without regulating the supply, you leave the market to criminal networks.” He emphasized that local innovations – cities leading the way – are often the precursors to necessary national reform.

Croatia’s Drug Decriminalization Experience

Sanja Mikulić, from the Institute for Public Health, presented Croatia’s experience with drug decriminalization, noting that possession forpersonal use is treated as a misdemeanor punishable by fine or treatment, with a significant reduction in criminal cases and less pressure on the justice system. She highlighted that th eapproach has led to more flexible procedures, reduced stigma, and easier rehabilitation, while alsosaving budget funds. The presentation concluded with positive effects of decriminalization, including reduced cases in criminal courts and more focus on serious drug-related crimes.

The warning from Portugal: why decriminalization is no longer enough

For two decades, Portugal has been the global poster child for reform. However, Joana Canêdo, a researcher and activist from Lisbon, delivered a critical warning: stagnation is dangerous.

While the 2001 decriminalization model famously reduced HIV rates and overdoses, Canêdo described the current system as a “prohibitionist variant.” The “Dissuasion Commissions,” once hailed as innovative, have become bureaucratic bottlenecks. Approximately 90% of those referred to them are non-problematic users (mostly of cannabis) who do not need treatment yet are subjected to a coercive administrative process.

Crucially, because the market remains illegal and unregulated, the system is struggling to adapt to new trends like crack cocaine. With recent political shifts in Portugal, aggressive policing and stop-and-search tactics have returned. The lesson for the rest of Europe is clear: Decriminalization without legal regulation and continuous investment in services will eventually hit a wall.

The pragmatic revolution: Czechia

However, the most significant innovation is occurring in Czechia. Dr. Jana Michailidu detailed the country’s revolutionary approach to “Psychomodulatory Substances” (such as Kratom and semi-synthetic cannabinoids).

Faced with a surge in new psychoactive substances, Czech politicians initially tried bans. When those bans failed immediately with new chemical analogues appearing weeks later, the government pivoted. They passed legislation creating a strict regulatory market. These substances are not banned, but neither are they unregulated. They are sold only to adults in licensed stores, with strict controls on dosage and packaging.

We managed to convince conservative politicians that regulation protects children better than bans” Dr. Michailidu explained. By taking the market out of the shadows, the state can control access – something prohibition has never achieved.

In her closing remarks, Ganna Dovbakh dismantled the metric favored by the new EU Strategy: the “kilogram seized.” She termed this the “Kilogram Fallacy.” Seizures are merely an indicator of police activity, not policy success. “You stop one route, ten more appear. You ban one substance; laboratories produce ten new ones. We are fighting a fire with a leaking hose” she argued.

 

Webinar on decriminalisation

Policy Webinar under the BOOST Project

4 December 2025 | 14:30–16:00 CET

Registration link | https://us02web.zoom.us/j/89055986872

Languages: English and Russian

 

Background and Rationale

Decriminalisation is defined as the removal of criminal sanctions for certain activities related to drug use and possession for personal use. Several actors in the field of drug policy have indicated that a punitive approach is counterproductive to achieving the health and welfare of humankind. There is no evidence that criminalisation of use, possession for personal use, and other related behaviours has positive impacts in terms of reducing both drug demand and supply.

Purpose and Objectives

  • Introduce the BOOST policy brief on decriminalisation to stakeholders across Europe: policymakers, community-led organisations, practitioners, funders
  • Present the evidence and recommendations on what works and where challenges remain when discussing about and adopting decriminalisation
  • Discuss why we need decriminalisation and what arguments can help and how to achieve this goal?
  • Enable dialogue among stakeholders decriminalisation: barriers, enablers, local contexts
  • Mobilise institutions, experts, communities and civil society networks to use the brief as an advocacy tool

Programme

Time Segment
14:30 – 15:37 Opening & overview – Milutin Milošević, DPNSEE Executive Director, Moderator
14:38 – 14:45 The BOOST project: General information and advocacy interventions – Igor Gordon, Program Team Lead, EHRA
14:45 – 14:55 The BOOST policy paper “Decriminalize! drug use and possession for personal use” – Marios Atzemis, DPNSEE Board member
14:55 – 14:05 Presentation of the new documents related to decriminalisation and human rights violations – Ganna Dovbakh, Executive Director and Maria Plotko, Senior Program Officer, EHRA

·      Updated Criminalisation Cost country profiles and regional comparison for CEECA

·      Regional CEECA report on CESCR rights violations of people who use drugs

15:05 – 15:15 Experts from countries implementing decriminalisation – John-Peter Kools, Trimbos institute, The Netherlands
15:15 – 15:22 Experts from countries implementing decriminalisation – Sanja Mikulić, Institute for Public Health, Croatia
15:23 – 15:30 Experts from countries implementing decriminalisation – Joana Canêdo, Portugal
15:30 – 15:38 Experts from countries implementing decriminalisation – Dr. Jana Michailidu, Czechia
15:40 – 15:55 Questions and answers
15:55 – 16:00 Closing – Ganna Dovbakh, EHRA Executive Director and EU Civil Society Forum on Drugs Chairperson

 

Policy Webinar: Universal Health Coverage for People Who Use Drugs

On 10 October 2025 (World Mental Health Day), the Eurasian Harm Reduction Association hosted a regional webinar under the EU4Health-funded BOOST project.

The webinar brought together speakers from WHO Europe, regional community networks and frontline services in Czechia, Lithuania and Romania. Participants joined from across Europe and neighbouring regions, including civil society organisations, community leaders, harm reduction professionals, clinicians and policymakers.

UHC that excludes PWUD is not universal

Opening the webinar, Ganna Dovbakh, Executive Director of EHRA, underlined that UHC cannot be called universal if it systematically excludes people who use drugs. She highlighted that in many countries, people who use drugs face a combination of criminalisation, stigma, fragmented services and poverty, which keeps them at the margins of health systems even where UHC frameworks formally exist.

Stela Bivol, from the WHO Regional Office for Europe, provided the global and regional policy context. She stressed that there is “no health without mental health” and no UHC without including people who use drugs and people with mental health and substance use conditions. She outlined WHO guidance on integrating mental health and substance use care into primary care, HIV and hepatitis services, and harm reduction, including the updated mhGAP recommendations and the new WHO clinical guidance on mental health and HIV.

Stela also drew attention to gender and intersectionality: women who use drugs, migrants, sex workers and LGBTIQ+ people often experience combined stigma, violence and rights violations that further reduce their access to care. Emergencies, such as the war in Ukraine, intensify mental health needs while disrupting services, making integration and task-sharing even more critical.

Communities as essential health actors

From the perspective of people who use drugs, Ligia Parodi (EuroNPUD) described UHC as “an empty promise” when people who use drugs are excluded by design through punitive drug policies and institutional discrimination. She stressed that fear of punishment, surveillance and institutional violence keeps people away from health services, and that many deaths and harms are the direct result of political choices.

Ligia highlighted community-led and peer-led initiatives, including BerLUN in Germany, Young Wave in Lithuania, and CASU and the women’s group MUSA in Portugal, which provide navigation, mutual support and advocacy on minimal budgets. These examples show that peers are already acting as health workers and system navigators, yet remain largely invisible and underfunded in UHC plans.

She called for decriminalisation, stable funding for community-led services, and meaningful participation of people who use drugs in decision-making bodies at national and EU levels, as well as in monitoring the quality and accessibility of UHC for key populations.

Integrated models from Czechia, Lithuania and Romania

The webinar showcased practical examples of integrating harm reduction and addiction care within UHC systems.

Radek Jurnikl (SANANIM, Czechia) presented a multidisciplinary outreach and low-threshold programme in Prague that combines social work, psychological support, nursing, psychiatric input and close collaboration with hospitals. The team provides street outreach, harm reduction services and on-site hepatitis C testing and treatment, as well as “hospital outreach” to ensure that patients discharged from hospital are immediately connected to OAT, shelter and follow-up support.

From Lithuania, Giedrius Likatavičius described the work of the Republican Centre for Addictive Disorders, which combines inpatient and outpatient care and runs an OAT programme with a dedicated budget line for people without health insurance. Social workers and nurses are embedded in low-threshold services to link clients to treatment and to HIV and hepatitis services. Lithuania’s model shows how mixed funding and dedicated lines for uninsured people can improve access, although stigma and weak financial incentives still limit decentralisation of OAT to primary care.

Monica Dan (ARAS, Romania) provided a contrasting picture from a more restrictive context. ARAS has offered harm reduction and OAT for decades, but services remain underfunded and not fully free of charge. Recent cuts to health insurance pathways have reduced access to treatment for many people who use drugs. At the same time, civil society must constantly resist new punitive legal initiatives. Monica underlined that without enabling legal frameworks and sustainable financing, even strong community-based services cannot deliver true UHC.

From evidence to advocacy

In the second half of the webinar, EHRA presented the joint BOOST advocacy strategy and the new policy brief: Advancing Universal Health Coverage for People Who Use Drugs in Europe, which translate these experiences into policy demands. The brief calls for harm reduction, OAT and mental health services to be explicitly included in UHC benefit packages; for peer navigators and low-threshold models to be recognised and funded; and for EU institutions to create or adapt funding mechanisms that reach community-led organisations.

Participants discussed the risk of over-medicalisation, the need to address self-medication and trauma, and the mental health needs of outreach workers and activists themselves. There was broad agreement that integrated and community-linked models are technically feasible and cost-effective, but remain politically fragile without decriminalisation, sustainable financing and meaningful community participation.

The webinar forms part of BOOST’s broader regional work on health, harm reduction and human rights. EHRA and partners will now use the policy brief and webinar outcomes to inform advocacy towards EU institutions, national governments and donors, ensuring that people who use drugs are not left behind in Europe’s push towards universal health coverage.

The recording from the webinar is available below

https://youtu.be/TQpJ3t5 KL_s

 

Webinar on data

The Drug Policy Network South Wast Europe hosted a webinar to present the recently published data related to harm reduction and HIV/AIDS in South East Europe on 26 November 2024. Besides presenting the data, it was an opportunity to discuss ways in which data should be more reliable and how to integrate data collected by civil society organisations in govrenmental reporting.

Following the welcome address by Nebojša Đurasović, DPNSEE President, we had excellent presentations:

  • Global State of Harm Reduction report – presented by Colleen Daniels, Deputy Director and Public Health Lead, Harm Reduction International (2024 available here>>>)
  • Harm Reduction in South East EuropeMarios Atzemis, DPNSEE Board member (available here>>>)
  • Civil Society Monitoring of Harm Reduction in EuropeIga Jeziorska, Senior Research Officer, Correlation – European Harm Reduction Network (available here>>>)
  • HIV/AIDS surveillance data for South East Europe (data from the European Centre for Disease Prevention and Control – ECDC) – Milutin Milošević, Executive Director, DPNSEE (available here>>>)

In addition, DPNSEE had sent data by countries and territories to its member organisations and governmental institutions. You can also download them here:

Albania Bosnia and Herzegovina Bulgaria Croatia Greece Kosovo*

Montenegro North Macedonia Romania Serbia Slovenia Turkey

DPNSEE informed that the European Centre for Disease Prevention and Control – ECDC will publish the HIV/AIDS surveillance in Europe 2024 (2023 data) report on 28 November at https://www.ecdc.europa.eu/. DPNSEE will process the new data and prepare new visuals in early 2025.

BOOST’s Peer-to-Peer Capacity-Building Webinar Series

As part of the BOOST Project, a series of webinars will be held in November for harm reduction organisations that are currently providing or planning to offer services in the fields of HIV and viral hepatitis.

The webinars aim to enhance the knowledge and skills of community-based and community-led organisations, helping them apply good practice models, tools, and methods to scale up integrated screening, testing, treatment and care for communicable diseases across Europe. Below are the sessions, dates and registration links.

Community-led approaches to HIV/VH/STIs screening, testing, treatment and care for people who use drugs

November 6th, 2024 | 16:00h CET

https://us02web.zoom.us/meeting/register/tZwsd-iqrTwjE9z9iIbtFYOyuWbBspWo6qF-

Optimising data collection: a guide to COBATEST standardised data collection tools

November 13th, 2024 | 16:00h CET

https://us02web.zoom.us/meeting/register/tZcvc-6srT0qE9B6Qb0cjTND6fW9C8s-nROi

Current best practices on community-based HIV/VH/STIs services

November 20th, 2024 | 16:00h CET

https://us02web.zoom.us/meeting/register/tZYrd–sqTkjHNPfQAKCa40Eediiygpyhi-h

Improving linkage to care in harm reduction settings

November 27th, 2024 | 16:00h CET

https://us02web.zoom.us/meeting/register/tZwtf-uhrjIqE9QiGDx6GveFV66wzWfmiQ3m

 

Harm reduction services for people who use drugs recreationally

The Alliance for Public Health organises webinar “Introducing harm reduction services for people who use drugs recreationally in EECA and the Balkans”, with the support from ReGeneration and DPNSEE.

Recreational drug use is on the rise, but at the same time young people who engage in it are not properly targeted by harm reduction services and don’t receive the necessary support, information and commodities they need to prevent them from turning to problematic use and all the relevant consequences.

On this webinar international experience on planning and implementing harm reduction programs specifically for this target population will be shared. Also, the draft guide that on this topic will be presented.

The Agenda includes topics:

  • Introducing the key principles and the justification behind the need to advocate for, develop and offer HR services for people who use recreationally.
  • Promoting Safety, Health, and Well-being: The need for Systematic implementation of Harm Reduction Strategies in Southeastern European Festivals.
  • Ukrainian experience on harm reduction services for people who use drugs recreationally.
  • #SafeParty – good practice example of multi-sectoral approach in nightlife harm reduction and recreation settings.
  • Q&A and Discussion.

This webinar will be useful for program managers, advocates, policy makers and communities from across the region to help them inform their decisions and actions.

The webinar will be held via Zoom platform on Tuesday 25 July, from 11:00 to 12:30 CET. Translations will be available in English, Russian, BHCS and Albanian.

Please register to participate following this link>>>.

 

An interesting discussion about the harm reduction crisis in SEE

On the 20th of April 2022, the three Networks organized a Webinar on Harm reduction crisis in South East Europe. During this event, national decision-makers from the region, researchers, harm reduction service providers, community and civil society representatives came together to present and discuss the key findings of the research activities.

Correlation – European Harm Reduction Network, the Eurasian Harm Reduction Association and the Drug Policy Network of South-Eastern Europe have been working together to advocate for addressing the harm reduction crisis in South East Europe since 2019.

Countries of South-Eastern Europe and the Balkans, including Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Romania and Serbia, are experiencing relatively high levels of HIV and HVC infection among people who inject drugs. However, due to limited domestic resources and the gradual withdrawal of the Global Fund from the region, the governments of these countries are facing a lack of resources to continue the long-term funding of comprehensive harm reduction programmes.

During this webinar, C-EHRN, EHRA and DPNSE present the research Crisis in harm reduction funding: The impact of transition from Global Fund to Government support and opportunities to achieve sustainable harm reduction services for people who inject drugs in Albania, Bosnia and Herzegovina, Bulgaria, Kosovo*, Montenegro, Romania and Serbia they have conducted in the area and discuss its key findings, which include among others:

  • Common challenges of scaling-up harm reduction programmes in the countries of South-Eastern Europe.
  • Consequences of the limited funding of the harm reduction services for public health and national healthcare systems.
  • Opportunities available for the governments of the region to act and invest funds and efforts in effective and proven models of harm reduction in their respective countries.

Building upon this research, this publication, and also policy briefing and factsheet, highlight opportunities available for the governments of the region to act and invest funds and efforts in effective and proven models of harm reduction in their respective countries.

Recording of the Webinar is available below.

Webinar on the brain development in adolescence and substance use

The Slovenian NCD Alliance invites you to a free webinar “The brain development in adolescence and substance use in the context of prevention science, policy & practice“, which will host three of the most important international experts in this field.

The webinar is organized as part of the celebration of World Drug Day (26 June) and the 15th anniversary of the UTRIP Institute (23 June). Priority for registration and participation will be given to the participants from the South Eastern European countries, especially those from Balkan region.

The seminar will be conducted in the form of a Webinar via ZOOM on Wednesday, 23 June 2021 from 15.00 to 18.00 (CEST time zone), and will be held in English.

The deadline for registrations is Tuesdaz 22 June 2021 via the form following this link˃˃˃. After registration, you will receive an email confirming registration and a ZOOM link for the Webinar.

The seminar is organized within the project “Because alcohol is not milk – advocacy in the field of alcohol policy”, which is supported by the “Active Citizens Fund” in Slovenia 2014 – 2021.

A great insight into the new EU Drugs Strategy

DPNSEE hosted the Webinar on EU Drugs Strategy 2021 – 2025 on Wednesday 24 March 2021. The Webinar was supported by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

The webinar was supposed to serve as a source of inspiration to support all those involved process of design, implementation and evaluation of drug strategies.

The EU Drugs Strategy 2021 – 2025 was presented by Danilo Ballotta, Coordinator – Institutional relations at the EMCDDA (link to Danilo’s presentation>>>).

Iga Jeziorska, from Youth Organisations for Drug Action, Chair of the Working Group on the EU Action Plan at the EU Civil Society Forum on Drugs (link to Iga’s presentation>>>) and Adrià Cots Fernández, Research and Advocacy Officer, International Drug Policy Consortium spoke about the civil society involvement in the process of designing the Strategy.

A more critical view on the Strategy was offered by Péter Sárosi from the Rights Reporter Foundation (link to Péter’s presentation>>>).

Discussions in three separate discussion rooms followed on three main pillars of the Strategy: Reducing supply (facilitated by Željko Petković, Assistant Director, Service for Combatting Drug Abuse at the Croatian Institute of Public Health), Reducing demand (facilitated by Matej Košir, Deputy Chairperson, Vienna NGO Committee on Narcotic Drugs, UTRIP Institute, Slovenia) and Harm reduction (facilitated by Marios Atzemis, DPNSEE Board member, European AIDS Treatment Group Greece).

More than 70 representatives of governmental organisations, both on national and local level, academia, civil society organisations, international organisations and donor community participated.

The Webinar offered a comprehensive and interesting insight into the Strategy and caused an interesting discussion and exchange of views.

The 1961 Single Convention on Narcotic Drugs: Sixty Years of an Epic Fail?

In 1961, the Member States of the United Nations set themselves a goal to eliminate illegal opium production by 1979 and that of cannabis and coca by 1989. In 1998, they proclaimed to be ready to achieve a world without drugs within 10 years.

Meanwhile, the use of illicit substances has increased at twice the rate of the world population, and today production and trafficking of drugs are completely out of control.

Sixty years of prohibitionist policies and the War on Drugs have caused more damages than those caused by the substances themselves in sanitary, social, criminal, environmental and economic terms.

Science for Democracy organises a webinar on 30 March, from 6 to 8 pm CET to mark the 60th Anniversary of the adoption of the 1961 UN Single Convention on Narcotic Drugs.

The webinar will address the historical background of the UN Conventions on narcotics and will look at the future of drug policy with experts and activists from around the world.

To register, please follow this link>>>.